These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10614688)

  • 1. Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.
    Lewis DF; Lake BG; George SG; Dickins M; Eddershaw PJ; Tarbit MH; Beresford AP; Goldfarb PS; Guengerich FP
    Toxicology; 1999 Nov; 139(1-2):53-79. PubMed ID: 10614688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
    Chang TK; Chen J; Benetton SA
    Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.
    Don MJ; Lewis DF; Wang SY; Tsai MW; Ueng YF
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2535-8. PubMed ID: 12852960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform.
    Lewis DF; Bird MG; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 2000 Jan; 30(1):1-25. PubMed ID: 10659948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
    Lewis DF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.
    Krusekopf S; Roots I; Hildebrandt AG; Kleeberg U
    Xenobiotica; 2003 Feb; 33(2):107-18. PubMed ID: 12623754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
    Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
    Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
    Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modelling of human CYP1A2 based on the CYP2C5 crystallographic template structure.
    Lewis DF; Lake BG; Dickins M; Ueng YF; Goldfarb PS
    Xenobiotica; 2003 Mar; 33(3):239-54. PubMed ID: 12637242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.
    Lewis DF; Lake BG; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 1999 Apr; 29(4):361-93. PubMed ID: 10375007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.
    Juvonen RO; Jokinen EM; Javaid A; Lehtonen M; Raunio H; Pentikäinen OT
    Chem Biol Drug Des; 2020 May; 95(5):520-533. PubMed ID: 32060993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
    Doostdar H; Burke MD; Mayer RT
    Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transforming growth factor-beta1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein expression in primary rat hepatocytes.
    Müller GF; Döhr O; El-Bahay C; Kahl R; Abel J
    Arch Toxicol; 2000 May; 74(3):145-52. PubMed ID: 10877000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
    Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
    Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.
    Uno S; Dragin N; Miller ML; Dalton TP; Gonzalez FJ; Nebert DW
    Free Radic Biol Med; 2008 Feb; 44(4):570-83. PubMed ID: 17997381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.